Aditxt, Inc. Accounts Payable and Accrued Liabilities
Aditxt, Inc. (ADTX) had Accounts Payable and Accrued Liabilities of $971.46 thousand as of 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Balance Sheet › Liabilities
us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent · last filed 2025-03-31
- 2024-12-31: Accounts Payable and Accrued Liabilities $971.46K.
- 2024-09-30: Accounts Payable and Accrued Liabilities $1.13M.
- 2024-06-30: Accounts Payable and Accrued Liabilities $667.63K.
- 2024-03-31: Accounts Payable and Accrued Liabilities $413.30K.
| Period end | Accounts Payable and Accrued Liabilities |
|---|---|
| 2024-12-31 | $971.46K 10-K · filed 2025-03-31 |
| 2024-09-30 | $1.13M 10-Q · filed 2024-11-18 |
| 2024-06-30 | $667.63K 10-Q · filed 2024-08-19 |
| 2024-03-31 | $413.30K 10-Q · filed 2024-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |